Creades AB 0QI9.L Stock
Creades AB Price Chart
Creades AB 0QI9.L Financial and Trading Overview
Creades AB stock price | 68 SEK |
Previous Close | 77.94 SEK |
Open | 0 SEK |
Bid | 0 SEK x 0 |
Ask | 0 SEK x 0 |
Day's Range | 0 - 0 SEK |
52 Week Range | 0 - 99.45 SEK |
Volume | 5.52K SEK |
Avg. Volume | 4.83K SEK |
Market Cap | 10.76M SEK |
Beta (5Y Monthly) | 1.044444 |
PE Ratio (TTM) | 0.13593021 |
EPS (TTM) | 5.8 SEK |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0QI9.L Valuation Measures
Enterprise Value | 10.05B SEK |
Trailing P/E | 0.13593021 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | -0.00766779 |
Price/Book (mrq) | 1.1496644 |
Enterprise Value/Revenue | -7.163 |
Enterprise Value/EBITDA | -7.694 |
Trading Information
Creades AB Stock Price History
Beta (5Y Monthly) | 1.044444 |
52-Week Change | -0.063% |
S&P500 52-Week Change | 20.43% |
52 Week High | 99.45 SEK |
52 Week Low | 0 SEK |
50-Day Moving Average | 83.47 SEK |
200-Day Moving Average | 80.65 SEK |
0QI9.L Share Statistics
Avg. Volume (3 month) | 4.83K SEK |
Avg. Daily Volume (10-Days) | 4.17K SEK |
Shares Outstanding | 12.47M |
Float | 53.35M |
Short Ratio | N/A |
% Held by Insiders | 47.16% |
% Held by Institutions | 15.29% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.4 |
Trailing Annual Dividend Yield | 1.79% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | 10:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 93.08% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -7.89% |
Return on Equity (ttm) | -12.80% |
Income Statement
Revenue (ttm) | -1403000064 SEK |
Revenue Per Share (ttm) | -10.334 SEK |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | -4203000000 SEK |
EBITDA | -1306249984 SEK |
Net Income Avi to Common (ttm) | -1286000000 SEK |
Diluted EPS (ttm) | 5.795 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 534M SEK |
Total Cash Per Share (mrq) | 3.93 SEK |
Total Debt (mrq) | 3M SEK |
Total Debt/Equity (mrq) | 0.03 SEK |
Current Ratio (mrq) | 11.922 |
Book Value Per Share (mrq) | 68.517 |
Cash Flow Statement
Operating Cash Flow (ttm) | 129M SEK |
Levered Free Cash Flow (ttm) | -933249984 SEK |
Profile of Creades AB
Country | United Kingdom |
State | N/A |
City | Stockholm |
Address | Ingmar Bergmans gata 4 |
ZIP | 10216 |
Phone | 46 8 41 20 11 00 |
Website | https://www.creades.se |
Industry | |
Sector(s) | |
Full Time Employees | 7 |
Creades AB is a private equity and venture capital investment firm specializing in seed/startup, early, mid & late venture, emerging growth, middle market, growth capital and buyout investments. The firm typically invests in small and medium-sized public and private companies. It focuses on Swedish companies. The firm seeks to invest between SEK100 ($15.51 million) and SEK300 million ($46.53 million). The firm prefers to take a majority stake and seat on the board of directors of its portfolio companies. The firm uses personal and balance sheet capital for making investments. Creades AB was founded in 2011 and is based in Stockholm, Sweden.
Q&A For Creades AB Stock
What is a current 0QI9.L stock price?
Creades AB 0QI9.L stock price today per share is 68 SEK.
How to purchase Creades AB stock?
You can buy 0QI9.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Creades AB?
The stock symbol or ticker of Creades AB is 0QI9.L.
How many shares does Creades AB have in circulation?
The max supply of Creades AB shares is 136.57K.
What is Creades AB Price to Earnings Ratio (PE Ratio)?
Creades AB PE Ratio is 0.11734254 now.
What was Creades AB earnings per share over the trailing 12 months (TTM)?
Creades AB EPS is 5.8 SEK over the trailing 12 months.